Session Details

[27-51-pm1]Clinical Pharmacy 1, Drug information/Clinical trials

Fri. Mar 27, 2026 1:10 PM - 3:10 PM JST
Fri. Mar 27, 2026 4:10 AM - 6:10 AM UTC
Room 51 (B303, Bldg. 1, Area 2 [3F])
Discusser: Yoichi Hasegawa, Susumu Kawano

[27-51-pm1-01S]Predictivity of the nonclinical toxicity studies on adverse events in the clinical trials of hyperlipidemia treatment drugs

○Ami Mizuta1, Erika Ishida1, Masaki Takaishi1, Akio Kobayashi1 (1. Pharm. Sci., IUHW.)

[27-51-pm1-02S]Reporting profiles of MMF-related hematologic toxicities: A JADER-based comparison between lupus nephritis
and kidney transplant patients

○Moeka Ogawa1, Masahiro Kobayashi2,3, Haruki Yamamoto2,3, Tatsuya Okuwaki3, Katsuya Otori2,3 (1. Grad. Sch. Pharm., Kitasato Univ., 2. Sch. Pharm., Kitasato Univ., 3. Pharm. Dept., Kitasato Univ. Hosp.)

[27-51-pm1-03S]Association between statin medications and rheumatoid arthritis based on the JMDC claims database

○Tomonao Hashimoto1, Satoshi Yokoyama1, Takaya Uno1, Kouichi Hosomi1 (1. Faculty of Pharmacy, Kindai University)

[27-51-pm1-05S]Analysis of unlisted items in the drug interview form for antibody drugs

○Nagisa Otsuka1 (1. Coll. of Pharm., Kinjo Gakuin Univ)

[27-51-pm1-06S]Analysis of Adverse Drug Reaction Cases Potentially Involving Pharmaceutical Excipients

○Aimi Kato1,2 (1. Coll. of Pharm., Kinjo Gakuin Univ., 2. Fac. of Pharm., Meijo Univ.)

[27-51-pm1-07S]Drug-Induced Depression Based on the FDA Adverse Event Reporting System (FAERS) Database

○Fuko Otaki1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm Univ)

[27-51-pm1-08S]Construction of an Nrf2 Agonist Prediction Model and Its Application to Skin Adverse Event Analysis Based on FAERS

○Nobuaki Kuribayashi1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm Univ)

[27-51-pm1-09S]Identification of Structural Features Involved in Severe Skin Adverse Reactions Using FAERS

○Kaito Inden1, Mizuho Asada1, Yoshihiro Uesawa1 (1. Meiji Pharm Univ)

[27-51-pm1-10S]Seasonal pattern of cerebral infarction reports among SGLT2 inhibitor users: A Japanese Adverse Drug Event Report database analysis

○Kaito Miyanohara1, TAKUYA IMATOH1, KOHEI OYABU1, KEISUKE MIGITA1 (1. Pharm. Sci., Fukuoka University)